Eosinophils are granulocytic white blood cells characterized by a typically bilobed nucleus and large eosinophilic cytoplasmic granules. They participate in defense against certain parasites, allergic inflammation, immune regulation, and tissue inflammatory responses.
Eosinophils are granulocytic white blood cells involved in immune defense and inflammation. They are particularly associated with responses to certain parasitic organisms and with allergic and type 2 inflammatory reactions.
Eosinophils are readily recognized on routine peripheral blood smears by their typically bilobed nucleus and numerous large cytoplasmic granules that stain red, orange, or pink with the acidic dye eosin.
Although eosinophils normally represent only a small proportion of circulating leukocytes, they contain potent granule proteins, enzymes, lipid mediators, and cytokines capable of producing substantial effects within tissues.
| Feature | Eosinophil Characteristic |
|---|---|
| Cell type | Granulocyte |
| Typical proportion | Approximately 1 to 4% of circulating leukocytes |
| Nucleus | Usually bilobed |
| Granules | Large eosinophilic specific granules |
| Production site | Bone marrow |
| Major roles | Parasite defense, allergic inflammation and immune regulation |
Eosinophils belong to the granulocyte group of leukocytes together with neutrophils and basophils.
Granulocytes possess conspicuous cytoplasmic granules and undergo characteristic nuclear segmentation during maturation.
Mature eosinophils are generally approximately 12 to 17 micrometers in diameter on stained blood preparations, although measurements vary with preparation technique.
They are therefore somewhat larger than erythrocytes and similar in general size to other granulocytes.
The mature eosinophil nucleus is most commonly divided into two lobes connected by a narrow bridge of chromatin.
This bilobed configuration is an important morphological feature used to distinguish eosinophils from other leukocytes.
The cytoplasm contains numerous large specific granules that are usually distributed throughout the cell.
These granules stain strongly with eosin and often appear bright red-orange on commonly used hematological stains.
Eosinophil specific granules contain highly active proteins and enzymes involved in host defense and inflammation.
Many granules possess a distinctive internal organization that can be demonstrated ultrastructurally.
Major basic protein is an abundant eosinophil granule protein with cytotoxic properties.
It can contribute to damage of certain parasites but can also injure host tissues when released during excessive or persistent inflammation.
Eosinophil cationic protein is another granule-associated protein with cytotoxic and antimicrobial properties.
Its release contributes to eosinophil-mediated inflammatory activity.
Eosinophil peroxidase is a granule enzyme involved in oxidative reactions that can contribute to antimicrobial and cytotoxic activity.
Products generated through these reactions can affect both invading organisms and surrounding host tissues.
Eosinophil granules also contain eosinophil-derived neurotoxin, a ribonuclease with biological activities relevant to host defense and inflammation.
Its functions are part of the broader repertoire of eosinophil granule-mediated responses.
| Granule Component | General Role |
|---|---|
| Major basic protein | Cytotoxic activity and parasite-associated defense |
| Eosinophil cationic protein | Cytotoxic and antimicrobial effects |
| Eosinophil peroxidase | Oxidative antimicrobial and inflammatory activity |
| Eosinophil-derived neurotoxin | Ribonuclease and immune-associated activity |
Eosinophils are strongly associated with immune responses against certain helminths and other multicellular parasites.
Large parasites cannot always be engulfed efficiently by individual phagocytes, so eosinophils can release toxic granule contents onto their surfaces.
Eosinophils possess receptors capable of interacting with antibody-coated targets.
This allows immune recognition mechanisms to help direct eosinophil activity toward selected organisms or structures.
Degranulation releases stored eosinophil granule proteins into the extracellular environment.
This can provide effective cytotoxic activity but may also produce collateral tissue injury if mediator release is excessive.
Eosinophils frequently accumulate in tissues affected by allergic inflammation.
They are particularly associated with disorders involving type 2 immune responses, including some forms of asthma and other allergic diseases.
Type 2 immune responses involve coordinated activity among T helper 2 cells, innate lymphoid cells, eosinophils, mast cells, basophils, and other cell populations.
Cytokines such as interleukin-4, interleukin-5, and interleukin-13 are important components of these responses.
Interleukin-5 (IL-5) is particularly important in eosinophil biology.
It promotes eosinophil differentiation, survival, activation, and mobilization and is a major cytokine associated with eosinophilic inflammation.
Eosinophils can accumulate within the airways in certain forms of asthma.
Their mediators can contribute to airway inflammation, epithelial injury, mucus-related changes, and altered airway responsiveness.
Elevated eosinophil numbers or tissue eosinophil accumulation can occur in allergic conditions involving the respiratory tract, skin, gastrointestinal tract, and other tissues.
The importance of eosinophils varies among individual diseases and among patients with the same clinical diagnosis.
In addition to preformed granule proteins, activated eosinophils can produce lipid mediators, cytokines, chemokines, and growth factors.
These substances allow eosinophils to influence vascular responses and the activity of nearby immune and structural cells.
Eosinophils can synthesize cysteinyl leukotrienes, which are potent lipid mediators involved in inflammatory responses.
These molecules can affect vascular permeability, mucus production, and smooth muscle behavior.
Eosinophils can produce or store a variety of cytokines and other signaling molecules.
Through these mediators they can communicate with lymphocytes, epithelial cells, mast cells, fibroblasts, and other cells.
Eosinophils originate from hematopoietic stem cells through myeloid progenitor pathways in the bone marrow.
Developing eosinophils undergo several recognizable precursor stages before mature cells enter the bloodstream.
The bone marrow is the primary site of eosinophil production.
During maturation, eosinophil precursors develop their characteristic specific granules and bilobed nuclear morphology.
Eosinophil development is regulated by cytokines and transcriptional programs associated with granulocyte differentiation.
IL-5 has a particularly prominent role in promoting the eosinophil lineage.
Only a fraction of the body's eosinophils are present in peripheral blood at any given time.
Circulating eosinophils can migrate into tissues in response to chemokines, adhesion signals, and inflammatory mediators.
Eosinophils normally occur in selected tissues, particularly mucosal regions of the gastrointestinal tract.
They can accumulate in much larger numbers at sites of allergic inflammation, parasitic infection, or eosinophilic disease.
Eosinophils leave the circulation through regulated interactions with vascular endothelium.
The recruitment process involves adhesion molecules, chemokines, and other signals that direct eosinophils toward particular tissues.
Eotaxins are chemokines strongly associated with eosinophil recruitment.
They interact with chemokine receptors on eosinophils and help guide these cells toward sites of type 2 inflammation.
The chemokine receptor CCR3 is highly expressed by eosinophils.
Binding of eotaxins and related chemokines to CCR3 contributes to eosinophil migration and tissue accumulation.
Eosinophils are among the easiest leukocytes to recognize because of their strongly eosinophilic granules and characteristic bilobed nucleus.
The granules are usually large, relatively uniform, and distributed throughout the cytoplasm.
Neutrophils generally have nuclei with several lobes and relatively pale, fine cytoplasmic granules.
Eosinophils typically have two nuclear lobes and much larger red-orange granules.
Basophils contain dark blue-purple granules that frequently obscure the nucleus.
Eosinophils contain bright red-orange granules and usually have a clearly visible bilobed nucleus.
| Feature | Neutrophils | Eosinophils | Basophils |
|---|---|---|---|
| Nucleus | Usually multilobed | Usually bilobed | Bilobed or irregular, often obscured |
| Granules | Fine and relatively pale | Large red-orange granules | Large dark blue-purple granules |
| Relative abundance | Most abundant | Usually 1 to 4% | Usually less than 1% |
| Major role | Rapid phagocytic defense | Parasite defense and allergic inflammation | Hypersensitivity and inflammatory mediator release |
Eosinophils can be reported as a percentage of total circulating leukocytes or as an absolute eosinophil count.
The absolute count is particularly useful when evaluating suspected eosinophilic disorders because percentages can be affected by changes in other leukocyte populations.
Eosinophilia refers to an increased number of eosinophils in peripheral blood.
It can occur in allergic disorders, parasitic infections, medication reactions, inflammatory conditions, immunological disorders, endocrine conditions, and certain neoplastic diseases.
Some tissue-invasive helminth infections can produce substantial eosinophilia.
The presence or absence of eosinophilia depends on the parasite, stage of infection, tissue involvement, and host immune response.
Peripheral or tissue eosinophilia can accompany asthma, allergic rhinitis, atopic dermatitis, and other allergic conditions.
However, eosinophil counts alone do not define the presence or severity of all allergic diseases.
Some medication hypersensitivity reactions are associated with eosinophilia.
Clinical significance depends on associated symptoms, organ involvement, timing, and the degree of eosinophil elevation.
Hypereosinophilia describes a substantial elevation in eosinophil numbers based on defined clinical and laboratory criteria.
Persistent eosinophil elevation can be important because activated eosinophils may infiltrate tissues and cause organ damage.
Hypereosinophilic syndromes are a heterogeneous group of disorders characterized by persistent eosinophilic abnormalities with associated clinical consequences in appropriate diagnostic contexts.
Potentially affected organs include the skin, lungs, gastrointestinal tract, heart, and nervous system.
Some patients with asthma have prominent eosinophilic airway inflammation.
This inflammatory phenotype has particular clinical importance because therapies targeting eosinophil-associated pathways may be used in selected patients.
Excessive eosinophil accumulation can occur within different regions of the gastrointestinal tract.
The anatomical location and depth of tissue involvement influence the clinical manifestations of these disorders.
Eosinopenia refers to a reduction in circulating eosinophils.
Low counts may occur during physiological stress or corticosteroid exposure, but isolated eosinopenia generally receives less diagnostic emphasis than eosinophilia.
The same granule proteins that help eosinophils attack pathogens can injure host tissues when released inappropriately or persistently.
This dual role is important in chronic eosinophilic inflammatory disorders.
Eosinophils can release cytokines and growth factors that influence fibroblasts, epithelial cells, extracellular matrix deposition, and tissue repair.
Persistent eosinophilic inflammation can therefore contribute to structural remodeling in affected organs.
Eosinophils and mast cells frequently interact during allergic inflammation.
Mast-cell mediators can promote eosinophil recruitment and activation, while eosinophil-derived products can modify local inflammatory responses.
Basophils and eosinophils both participate in type 2 immune responses but have different granule contents, morphology, abundance, and functional specializations.
Basophils are particularly associated with IgE-mediated mediator release, while eosinophils are prominent effector cells in selected parasitic and eosinophilic inflammatory responses.
Helper T-cell cytokines can strongly influence eosinophil development and recruitment.
In particular, type 2 helper T-cell responses provide signals that promote eosinophilic inflammation.
| Feature | Key Point |
|---|---|
| Cell class | Granulocyte |
| Typical abundance | Approximately 1 to 4% of circulating leukocytes |
| Nucleus | Usually bilobed |
| Granule appearance | Large red-orange eosinophilic granules |
| Important granule protein | Major basic protein |
| Major developmental cytokine | Interleukin-5 |
| Important chemokine receptor | CCR3 |
| Major host-defense association | Certain parasitic infections |
| Major inflammatory association | Allergic and type 2 inflammation |
| Production site | Bone marrow |
Eosinophils are specialized granulocytes whose morphology reflects their functional specialization. Their large eosinophilic granules contain potent proteins capable of damaging biological targets, while their bilobed nucleus provides a characteristic feature for identification in peripheral blood and tissues.
Blood serves as a transport route between eosinophil production in the bone marrow and sites of immune activity. Chemokines and endothelial adhesion mechanisms allow eosinophils to leave the circulation and accumulate in tissues where parasite-associated or type 2 inflammatory responses are occurring.
The protective activity of eosinophils must be carefully regulated because their cytotoxic granule proteins can affect both pathogens and host tissues. This balance explains their dual importance in host defense and disease, particularly in parasitic immunity, asthma, allergic inflammation, and eosinophilic disorders affecting multiple organ systems.